GO:0004504 peptidylglycine monooxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004504 (peptidylglycine monooxygenase activity) catalyzes the ascorbate- and oxygen-dependent 2-hydroxylation of peptidyl-glycine substrates, the first step in peptide C-terminal alpha-amidation.
• The enzyme is also known as peptidylglycine alpha-amidating monooxygenase (PAM) and is essential for activating many bioactive peptides, including adrenomedullin and growth hormone-releasing hormone [3,6].
• PAM activity is pH-dependent and can be stimulated by granule-associated factors, linking its regulation to the secretory pathway.
• Altered PAM activity is associated with hepatic cirrhosis, rheumatoid arthritis, and diabetes risk, making it a candidate biomarker and therapeutic target [6,7,8].
• Monomeric growth hormone can exhibit intrinsic peptidylglycine monooxygenase activity, suggesting moonlighting functions beyond classical PAM.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect PAM gene function in disease-relevant cell types [2,8].
Description
Peptidylglycine monooxygenase activity (GO:0004504) is a molecular function that catalyzes the conversion of peptidyl-glycine to peptidyl(2-hydroxyglycine) using ascorbate and molecular oxygen. This reaction is the first and rate-limiting step in the C-terminal alpha-amidation of peptide hormones and neuropeptides, a modification that is often required for their biological activity. The enzyme responsible, peptidylglycine alpha-amidating monooxygenase (PAM), is a bifunctional protein that also carries out the subsequent lyase step to generate the final alpha-amidated peptide. Because amidated peptides are involved in diverse physiological processes, including energy balance, insulin secretion, and vascular tone, understanding GO:0004504 is critical for researchers in endocrinology, neuroscience, and metabolism [2,6,8]. Recent studies have linked PAM activity to hepatic cirrhosis, rheumatoid arthritis, and diabetes risk, underscoring its clinical relevance [6,7,8]. This article provides a comprehensive overview of the mechanism, key genes, disease associations, and research methods for studying peptidylglycine monooxygenase activity.
peptidylglycine monooxygenase activity At A Glance
| GO ID | GO:0004504 |
|---|---|
| GO term | peptidylglycine monooxygenase activity |
| Ontology | molecular_function |
| Synonym | PAM-A, PAM activity, PAM-B, peptide alpha-amidating enzyme, peptide alpha-amide synthase activity, peptide-alpha-amide synthetase activity, peptidyl alpha-amidating enzyme activity, peptidylglycine 2-hydroxylase activity, peptidylglycine alpha-amidating monooxygenase activity, peptidylglycine alpha-hydroxylase activity, peptidylglycine,ascorbate:oxygen oxidoreductase (2-hydroxylating), synthase, peptide alpha-amide |
| Major function | Catalyzes the 2-hydroxylation of peptidyl-glycine, the first step in peptide C-terminal alpha-amidation |
| Cofactors | Ascorbate, copper, molecular oxygen |
| Reaction | peptidyl-glycine + ascorbate + O2 = peptidyl(2-hydroxyglycine) + dehydroascorbate + H2O |
| Subcellular location | Secretory granules, plasma membrane, extracellular |
| Related diseases | Hepatic cirrhosis, rheumatoid arthritis, diabetes, cancer |
What Is GO:0004504?
Peptidylglycine monooxygenase activity (GO:0004504) is defined as the catalysis of the reaction: peptidyl-glycine + ascorbate + O2 = peptidyl(2-hydroxyglycine) + dehydroascorbate + H2O. In simpler terms, it is an enzymatic activity that adds a hydroxyl group to the glycine residue at the C-terminus of a peptide, using ascorbate (vitamin C) as a cofactor and oxygen as a substrate. This reaction is the first step in a two-step process that converts a peptidyl-glycine into a bioactive alpha-amidated peptide.
Why Is peptidylglycine monooxygenase activity Important in Cell Biology?
Peptidylglycine monooxygenase activity is essential for the biosynthesis of numerous bioactive peptides that regulate critical physiological processes, including energy homeostasis, insulin secretion, and vascular function [2,3,8]. Dysregulation of this activity has been implicated in human diseases such as hepatic cirrhosis, rheumatoid arthritis, and diabetes, making it a potential biomarker and therapeutic target [6,7,8]. Moreover, the enzyme's dependence on ascorbate and copper links its function to nutritional status and metal homeostasis, with implications for oxidative stress and cellular metabolism [3,5].
• Required for the activation of peptide hormones such as adrenomedullin, which regulates vascular tone.
• Involved in energy balance through POMC neurons, where Fam172a-mediated histone lactylation regulates POMC expression.
• Associated with beta-cell cilia formation and insulin secretion in mice, linking PAM to diabetes risk.
• Low PAM activity in synovial fibroblasts is genetically linked to tissue damage in rheumatoid arthritis.
• PAM activity is pH-dependent and stimulated by granule-associated factors, indicating tight regulation in secretory pathways.
• Monomeric growth hormone can exhibit intrinsic PAM activity, suggesting moonlighting functions.
• PAM is a candidate therapeutic target for human diseases, including cancer and neurodegeneration.
• Inhibitors of PAM have been developed, providing tools for structure-activity relationship studies.
• PAM activity can be measured in patients with hepatic cirrhosis, offering diagnostic potential.
• CRISPR screening can identify regulators of PAM activity and its downstream effects [2,8].
What Happens During peptidylglycine monooxygenase activity?
Substrate Recognition and Binding
In simple terms: The enzyme grabs a peptide that ends with glycine and holds it in place.
Peptidylglycine monooxygenase (PAM) recognizes peptide substrates with a C-terminal glycine residue. The enzyme binds the peptide in its active site, positioning the glycine for hydroxylation. This step is essential for the subsequent amidation reaction.
Ascorbate-Dependent Hydroxylation
In simple terms: Using vitamin C and oxygen, the enzyme adds a hydroxyl group to the glycine.
In the presence of ascorbate and molecular oxygen, PAM catalyzes the 2-hydroxylation of the peptidyl-glycine, forming peptidyl(2-hydroxyglycine). This reaction consumes ascorbate and produces dehydroascorbate and water. The hydroxylation is the first step in the two-step amidation process.
Lyase-Mediated Amidation
In simple terms: A second enzymatic step removes the modified glycine to leave an amide group.
Following hydroxylation, the peptidyl(2-hydroxyglycine) intermediate is converted to the final alpha-amidated peptide by a lyase activity, which is also carried by the bifunctional PAM enzyme. This step releases glyoxylate and generates the bioactive amidated peptide.
pH-Dependent Regulation
In simple terms: The enzyme works best at a specific acidity, which can be adjusted by other factors.
PAM activity is pH-dependent, with optimal activity in the slightly acidic environment of secretory granules. A granule-associated factor can stimulate PAM activity in a pH-dependent manner, suggesting that the local environment regulates enzyme function.
Moonlighting Activity of Growth Hormone
In simple terms: Even growth hormone can act like PAM under certain conditions.
Monomeric species of growth hormone have been shown to exhibit peptidylglycine monooxygenase activity, indicating that this enzymatic function is not exclusive to PAM. This moonlighting activity may have physiological relevance.
Key Genes Involved in GO:0004504 peptidylglycine monooxygenase activity
The following genes and proteins are directly or indirectly involved in peptidylglycine monooxygenase activity and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PAM | Encodes peptidylglycine alpha-amidating monooxygenase, the primary enzyme with GO:0004504 activity | Central to peptide amidation; knockout models show defects in insulin secretion and energy balance [3,8] |
| POMC | Pro-opiomelanocortin, precursor to amidated peptides like alpha-MSH | Regulated by histone lactylation in POMC neurons; links to energy balance |
| FAM172A | Involved in histone lactylation in POMC neurons | Regulates POMC expression and energy balance; potential upstream regulator |
| ADM | Adrenomedullin, a peptide requiring amidation for activity | Measured in hepatic cirrhosis; biomarker for PAM activity |
| GH1 | Growth hormone, which can exhibit intrinsic PAM activity | Monomeric GH shows peptidylglycine monooxygenase activity |
| PAM-A | Splice variant of PAM | Isoform-specific functions in peptide amidation |
| PAM-B | Splice variant of PAM | Isoform-specific functions in peptide amidation |
| COPPER | Copper ions required for PAM catalysis | Copper homeostasis affects PAM activity |
| ASCORBATE | Vitamin C, cofactor for PAM | Ascorbate availability regulates PAM activity |
| O2 | Molecular oxygen, substrate for PAM | Oxygen tension affects PAM activity |
| Granule-associated factor | Stimulates PAM activity in a pH-dependent manner | Regulatory mechanism in secretory granules |
| PAM inhibitors | Small molecules that inhibit PAM | Tool compounds for studying PAM function |
| Beta-cell cilia | Structures affected by PAM in beta cells | PAM is important for cilia formation and insulin secretion |
| Synovial fibroblasts | Cells with low PAM activity in rheumatoid arthritis | Genetic link to tissue damage |
| Hepatic cirrhosis | Disease associated with altered PAM activity | PAM and adrenomedullin as biomarkers |
| Diabetes risk | PAM promotes diabetes risk through beta-cell independent mechanisms | Therapeutic target for diabetes |
| Cancer | PAM as a therapeutic target or biomarker | Potential role in oncology |
| Neurodegeneration | PAM as a therapeutic target | Potential role in neurodegenerative diseases |
How Is peptidylglycine monooxygenase activity Regulated?
Peptidylglycine monooxygenase activity is regulated at multiple levels. The enzyme's activity is pH-dependent and can be stimulated by a granule-associated factor, which may modulate its function within secretory granules. Additionally, the availability of cofactors such as ascorbate and copper influences enzymatic activity. In POMC neurons, histone lactylation mediated by Fam172a regulates POMC expression, indirectly affecting the substrate supply for PAM. Furthermore, PAM activity is important for beta-cell cilia formation and insulin secretion, suggesting a role in cellular signaling pathways.
peptidylglycine monooxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PAM | Hepatic cirrhosis | Knockout mouse models; patient-derived hepatocytes |
| PAM | Rheumatoid arthritis | Synovial fibroblast knockout; collagen-induced arthritis models |
| PAM | Diabetes | Beta-cell specific knockout; insulin secretion assays |
| POMC | Energy balance | POMC neuron-specific knockout; metabolic phenotyping |
| FAM172A | Energy balance | Knockout mice; histone lactylation analysis |
Hepatic Cirrhosis
Peptidylglycine alpha-amidating monooxygenase (PAM) activity and adrenomedullin levels are altered in patients with hepatic cirrhosis. Measurement of PAM and adrenomedullin may serve as biomarkers for disease severity and progression.
Rheumatoid Arthritis
Tissue damage in rheumatoid arthritis is genetically linked to low PAM activity in synovial fibroblasts. Reduced PAM activity may contribute to joint destruction, making it a potential therapeutic target.
Diabetes and Beta-Cell Function
PAM is important for beta-cell cilia formation and insulin secretion in mice. However, PAM also promotes diabetes risk through beta-cell independent mechanisms, indicating a complex role in glucose homeostasis.
Cancer and Neurodegeneration
PAM has been proposed as a therapeutic target or biomarker for human diseases including cancer and neurodegenerative disorders. Its role in activating peptide hormones and neuropeptides may influence tumor growth and neuronal survival.
From peptidylglycine monooxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of PAM knockout on peptide amidation? | PAM knockout cell lines (e.g., HEK293, Neuro2A) |
| How does a point mutation in PAM affect catalytic activity? | Point-mutation knock-in via CRISPR in cell lines |
| What is the impact of PAM overexpression on insulin secretion? | Beta-cell specific overexpression in mice |
| How does tagged PAM localize in secretory granules? | Knock-in of fluorescent tag (e.g., GFP) at PAM locus |
| Which genes regulate PAM activity? | CRISPR library screening in relevant cell types |
| Does PAM activity contribute to rheumatoid arthritis? | Synovial fibroblast knockout in arthritis models |
How to Study the peptidylglycine monooxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | PAM catalytic activity | Kinetic studies, inhibitor screening |
| CRISPR knockout screen | Genes affecting PAM activity | Identification of regulators |
| Peptidomics | Amidated peptide levels | Biomarker discovery |
| Fluorescence imaging | Subcellular localization | Trafficking studies |
| Western blot | PAM protein expression | Validation of knockout/overexpression |
| qPCR | PAM mRNA levels | Gene expression analysis |
| Insulin secretion assay | Beta-cell function | Diabetes research |
| Histone lactylation assay | Epigenetic regulation | Energy balance studies |
Enzymatic Activity Assays
Peptidylglycine monooxygenase activity can be measured using radiolabeled or fluorescent peptide substrates. These assays monitor the conversion of peptidyl-glycine to peptidyl(2-hydroxyglycine) in the presence of ascorbate and oxygen. Inhibitor studies can be performed to characterize enzyme kinetics.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate PAM activity or its downstream effects. For example, screens in POMC neurons or beta cells can uncover modifiers of energy balance and insulin secretion [2,8].
Proteomics and Peptidomics
Mass spectrometry-based peptidomics can quantify amidated peptides in biological samples, providing a readout of PAM activity. This approach can be used to identify novel substrates and biomarkers in diseases such as hepatic cirrhosis.
Imaging and Localization
Fluorescence microscopy of tagged PAM (e.g., GFP knock-in) allows visualization of its subcellular localization in secretory granules and on the plasma membrane. This can reveal dynamic changes in response to stimuli.
How CRISPR Can Be Used to Study GO:0004504 peptidylglycine monooxygenase activity
Knockout
CRISPR knockout of PAM or related genes (e.g., FAM172A) can abolish peptidylglycine monooxygenase activity, leading to defects in peptide amidation. These models are useful for studying the physiological consequences of loss of function in cell lines and animal models [2,8].
Point Mutation
Introducing point mutations in the catalytic domain of PAM via CRISPR can dissect the roles of specific residues in substrate binding and catalysis. Such models help validate structural predictions and inhibitor binding sites.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) or disease-associated mutations allows tracking of PAM localization and function in live cells. This approach can reveal isoform-specific roles and trafficking defects.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase PAM levels, enabling studies of gain-of-function effects on peptide amidation, insulin secretion, and disease phenotypes. Overexpression models are valuable for testing therapeutic hypotheses.
How EDITGENE Supports peptidylglycine monooxygenase activity Research
Researchers studying peptidylglycine monooxygenase activity-related genes often need to determine whether a candidate gene is causally involved in peptide amidation, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for peptidylglycine monooxygenase activity research.
Frequently Asked Questions About peptidylglycine monooxygenase activity
What is peptidylglycine monooxygenase activity?
Peptidylglycine monooxygenase activity (GO:0004504) is an enzymatic activity that catalyzes the hydroxylation of peptidyl-glycine to peptidyl(2-hydroxyglycine) using ascorbate and oxygen, the first step in peptide C-terminal alpha-amidation.
What genes are involved in peptidylglycine monooxygenase activity?
The primary gene is PAM, which encodes peptidylglycine alpha-amidating monooxygenase. Other related genes include POMC, FAM172A, and ADM [2,3,6].
What diseases are associated with peptidylglycine monooxygenase activity?
Altered PAM activity is associated with hepatic cirrhosis, rheumatoid arthritis, diabetes, and potentially cancer and neurodegeneration [3,6,7,8].
How is peptidylglycine monooxygenase activity regulated?
It is regulated by pH, granule-associated factors, and the availability of cofactors such as ascorbate and copper. Histone lactylation may also influence substrate supply [2,3,5].
What is the role of PAM in diabetes?
PAM is important for beta-cell cilia formation and insulin secretion in mice, but it also promotes diabetes risk through beta-cell independent mechanisms.
Can peptidylglycine monooxygenase activity be measured in patients?
Yes, PAM activity and adrenomedullin levels can be measured in patients with hepatic cirrhosis, serving as potential biomarkers.
What are the substrates of peptidylglycine monooxygenase?
Substrates are peptides with a C-terminal glycine residue, such as pro-adrenomedullin and pro-opiomelanocortin-derived peptides [3,6].
What cofactors are required for peptidylglycine monooxygenase activity?
The enzyme requires ascorbate (vitamin C), copper ions, and molecular oxygen for catalysis.
How can CRISPR be used to study peptidylglycine monooxygenase activity?
CRISPR can generate knockout, point mutation, knock-in, and overexpression models of PAM and related genes to study their function in peptide amidation and disease [2,8].
Is peptidylglycine monooxygenase a therapeutic target?
Yes, PAM is considered a therapeutic target or biomarker for human diseases including cancer, neurodegeneration, and metabolic disorders.
Conclusion
Peptidylglycine monooxygenase activity (GO:0004504) is a critical enzymatic function for the biosynthesis of bioactive peptides. Its dysregulation is linked to a range of human diseases, from hepatic cirrhosis to rheumatoid arthritis and diabetes. Advances in CRISPR-based models and screening technologies are enabling deeper insights into the regulation and therapeutic potential of this pathway. EDITGENE provides comprehensive services to support researchers in this field, from gene editing to bioinformatics.
References
- 1. Donlon J et al.. 2019. Peptidylglycine monooxygenase activity of monomeric species of growth hormone.. Heliyon 5(9):e02436 PMID: 31528749
- 2. Chen Z et al.. 2024. Histone lactylation mediated by Fam172a in POMC neurons regulates energy balance.. Nat Commun 15(1):10111 PMID: 39578459
- 3. Merkler DJ et al.. 2022. Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.. Br J Pharmacol 179(13):3306-3324 PMID: 35124797
- 4. Rhodes CH et al.. 1993. Structure-activity relationships among inhibitors of peptidylglycine amidating monooxygenase.. Ann N Y Acad Sci 689:663-6 PMID: 8373072
- 5. Perkins SN et al.. 1990. pH-dependent stimulation of peptidylglycine alpha-amidating monooxygenase activity by a granule-associated factor.. Endocrinology 127(6):2771-8 PMID: 2249628
- 6. Goetze JP et al.. 2023. Peptidylglycine α-amidating monooxygenase and adrenomedullin measurement in patients with hepatic cirrhosis.. Biomark Med 17(13):577-583 PMID: 37812053
- 7. Sheridan KJ et al.. 2026. Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha-Amidating Monooxygenase Activity in Synovial Fibroblasts.. Arthritis Rheumatol 78(9):1837-1849 PMID: 41797318
- 8. Chen YC et al.. 2025. Peptidylglycine alpha-amidating monooxygenase is important in mice for beta-cell cilia formation and insulin secretion but promotes diabetes risk through beta-cell independent mechanisms.. Mol Metab 96:102123 PMID: 40120979
